当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析 - 现金流量表

盟科药业-U

(688373)

  

流通市值:42.72亿  总市值:53.30亿
流通股本:5.25亿   总股本:6.56亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金71,051,858.1835,067,130.44136,564,457.9898,704,559.62
  收到的税费返还-7,116.29-97,876.92
  收到其他与经营活动有关的现金3,144,631.54486,110.293,583,922.633,204,188.86
  经营活动现金流入小计74,196,489.7235,560,357.02140,148,380.61102,006,625.4
  购买商品、接受劳务支付的现金121,952,806.8646,912,769.88415,605,712.61273,812,048.58
  支付给职工以及为职工支付的现金54,785,443.0630,134,745.33111,016,552.8978,427,804.8
  支付的各项税费10,458,533.091,028,859.2427,001,335.1327,509,790.85
  支付其他与经营活动有关的现金7,704,385.499,532,177.833,705,515.3115,742,911.79
  经营活动现金流出小计194,901,168.587,608,552.25587,329,115.94395,492,556.02
  经营活动产生的现金流量净额-120,704,678.78-52,048,195.23-447,180,735.33-293,485,930.62
二、投资活动产生的现金流量:
  收回投资收到的现金1,392,059,812.89848,173,313.792,987,343,569.581,864,014,475.13
  取得投资收益收到的现金3,719,749.168,618,023.0720,173,016.3840,580,461.27
  处置固定资产、无形资产和其他长期资产收回的现金净额--27,456.3128,000
  投资活动现金流入小计1,395,779,562.05856,791,336.863,007,544,042.271,904,622,936.4
  购建固定资产、无形资产和其他长期资产支付的现金259,932.3523,187914,765.4448,000
  投资支付的现金1,357,980,818.93812,864,268.512,491,831,053.841,565,086,550.13
  投资活动现金流出小计1,358,240,751.28812,887,455.512,492,745,819.281,565,134,550.13
  投资活动产生的现金流量净额37,538,810.7743,903,881.35514,798,222.99339,488,386.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,977,035-
  取得借款收到的现金71,702,238.6964,479,490.67105,000,000100,000,000
  筹资活动现金流入小计71,702,238.6964,479,490.67106,977,035100,000,000
  偿还债务支付的现金12,010,0005,500,00017,020,00010,500,000
  分配股利、利润或偿付利息支付的现金4,303,012.12,027,8186,542,266.074,554,331.74
  支付其他与筹资活动有关的现金7,716,039.18-15,319,991.1911,015,922.77
  筹资活动现金流出小计24,029,051.287,527,81838,882,257.2626,070,254.51
  筹资活动产生的现金流量净额47,673,187.4156,951,672.6768,094,777.7473,929,745.49
四、汇率变动对现金及现金等价物的影响-934,222.35-102,090.07143,372.07-3,394,068.68
五、现金及现金等价物净增加额-36,426,902.9548,705,268.72135,855,637.47116,538,132.46
  加:期初现金及现金等价物余额273,332,290.62273,332,290.62137,476,653.15137,476,653.15
  期末现金及现金等价物余额236,905,387.67322,037,559.34273,332,290.62254,014,785.61
补充资料:
  净利润-138,674,492.55--440,721,217.09-
  固定资产和投资性房地产折旧1,154,661.21-2,262,567.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,154,661.21-2,262,567.82-
  无形资产摊销439,071.2-492,740.52-
  长期待摊费用摊销1,528,453.14-2,999,610.23-
  递延收益摊销--500,000-
  处置固定资产、无形资产和其他长期资产的损失---27,456.31-
  固定资产报废损失-4,427.63---
  公允价值变动损失-4,261,022.11--17,081,843.88-
  财务费用4,813,649.95-12,015,538.85-
  存货的减少2,416,801.55--15,416,618.4-
  经营性应收项目的减少-2,882,985.89--24,409,153.56-
  经营性应付项目的增加-6,768,929.53--18,870,359.83-
  不涉及现金收支的投资和筹资活动金额其他项目--3,176,680.18-
  现金的期末余额236,905,387.67-273,332,290.62-
  减:现金的期初余额273,332,290.62-137,476,653.15-
  现金及现金等价物的净增加额-36,426,902.95-135,855,637.47-
公告日期2025-08-202025-04-242025-03-182024-10-25
审计意见(境内)标准无保留意见
TOP↑